SLC67A1 and glioma: To explore whether aberrant promoter methylation was responsible for the downregulation of SLC22A18 in glioma tissues, the methylation status of the SLC22A18 promoter and SLC22A18 expression were correlated in the 30 glioma specimens and the corresponding normal tissues.